Syndecan 1 (SDC1) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Syndecan 1 (SDC1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificitySyndecan 1 (SDC1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatfluorescein (FITC) conjugate
Size20 µg, 50 µg, 100 µg, 200 µg
Concentrationn/a
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSDC1 Antibody (FITC) is a Rabbit Polyclonal against SDC1 conjugated to FITC.
ImmunogenRecombinant human Syndecan-1 protein (23-254AA).
Other NamesSDC1, CD138, SDC, SYND1, syndecan, Syndecan 1, CD138 Antigen, Transmembrane protein 101, Putative NF-kappa-B-activating protein 130, TMEM101, SDC1, SDC1, SDC1, SDC1, CD138, CD138, CD138, CD138, SDC, SDC, SDC, SDC, SYND1, SYND1, SYND1, SYND1, syndecan, syndecan, syndecan, syndecan, Syndecan 1, Syndecan 1, Syndecan 1, Syndecan 1, CD138 Antigen, CD138 Antigen, CD138 Antigen, CD138 Antigen, Transmembrane protein 101, Transmembrane protein 101, Transmembrane protein 101, Transmembrane protein 101, Putative NF-kappa-B-activating protein 130, Putative NF-kappa-B-activating protein 130, Putative NF-kappa-B-activating protein 130, Putative NF-kappa-B-activating protein 130, TMEM101, TMEM101, TMEM101, TMEM101
Gene, Accession #SDC1, Gene ID: 6382, UniProt: P18827
Catalog #abx305257
Priceplease inquire
Order / More InfoSyndecan 1 (SDC1) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.